News aap Implantate AG

Equities

AAQ1

DE000A3H2101

Market Closed - Xetra Other stock markets 09:06:09 28/06/2024 pm IST			5-day change	1st Jan Change
1.21 ^EUR	-0.82%		+0.83%	+45.78%

2021	Aap Implantate AG Announces Sales Results for the Second Quarter and Half Year Ended 30 June 2021	CI
2021	Aap Implantate Ag Reports Earnings Results for the Full Year Ended December 31, 2020	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Aap Implantate AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	06/06	EQ
NVR: aap Implantate AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	31/05	EQ
Amendment of the terms and conditions of the bond completed; Bondholders can convert bonds into shares	23/05	EQ
Aap Implantate AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	22/04	EQ
Aap closes Q1 2024 with sales growth of 5.6% and positive developments at all operating levels and makes a strong start to Q2 2024	22/04	EQ
NVR: aap Implantate AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	19/04	EQ
Aap successfully places a 10% capital increase from authorized capital at EUR 1.10 with exclusion of subscription rights	19/04	EQ
Aap Implantate AG: aap postpones publication of the consolidated financial statements 2023 due to staff shortages	17/04	EQ
Aap 100% approval of the proposed resolution to amend the terms and conditions of the mandatory convertible bond 2023/2028	03/04	EQ
Aap Implantate AG: Capital increase from authorized capital with exclusion of subscription rights	18/03	EQ
Aap proposes to the bondholders of the mandatory convertible bond 2023/2028 an amendment to the bond terms and conditions to enable the bondholders to exercise their conversion rights earlier	05/03	EQ
After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year	15/02	EQ
Aap Implantate : with positive EBITDA in Q2 and H1/2021 for first time since focusing on trauma and significant sales growth of +74% (Q2) and +37% (H1)	13/21/13	PU
Aap Implantate : with positive EBITDA in Q2 and H1/2021 for first time since focusing on trauma and significant sales growth of +74% (Q2) and +37% (H1)	13/21/13	EQ
Aap Implantate AG Announces Sales Results for the Second Quarter and Half Year Ended 30 June 2021	27/21/27	CI
Q1/21: Successful start to the year with sales growth (+9%) and significant earnings improvement (+91%) despite still burdening COVID-19 pandemic - restructuring successes clearly visible	28/21/28	EQ
Aap Implantate Ag Reports Earnings Results for the Full Year Ended December 31, 2020	01/21/01	CI
2020 financial statements: visible results under restructuring with significantly improved Recurring EBITDA (+28%) in challenging times of COVID-19 pandemic	30/21/30	EQ
Aap Implantate AG Provides Earnings Guidance for the Year 2021	30/21/30	CI
Q1/2021: Solid start to year with 9% sales growth despite still burdening COVID 19 pandemic; more than 500 surgeries in US mark new high; Q2 order book well filled	26/21/26	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News aap Implantate AG

Equities

AAQ1

DE000A3H2101

Summary

Filters